Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q408588> ?p ?o }
Showing triples 1 to 83 of
83
with 100 triples per page.
- Q408588 subject Q7071513.
- Q408588 subject Q7334142.
- Q408588 subject Q8248726.
- Q408588 subject Q8297708.
- Q408588 subject Q8546974.
- Q408588 subject Q8732563.
- Q408588 subject Q8732564.
- Q408588 abstract "Vilazodone (United States trade name Viibryd VEYE-brid) is a serotonergic antidepressant developed by Clinical Data for the treatment of major depressive disorder. The chemical compound was originally developed by Merck KGaA (Germany). Vilazodone was approved by the FDA for use in the United States to treat major depressive disorder in 2011.".
- Q408588 atcPrefix "N06".
- Q408588 atcSuffix "AX24".
- Q408588 bioavailability "72.0".
- Q408588 casNumber "163521-12-8".
- Q408588 chEBI "70707".
- Q408588 fdaUniiCode "S239O2OOV3".
- Q408588 iupacName "5-(4-[4-(5-Cyano-1H-indol-3-yl)butyl]piperazin-1-yl)benzofuran-2-carboxamide".
- Q408588 pubchem "6918313".
- Q408588 thumbnail Vilazodone2DACS4.svg?width=300.
- Q408588 wikiPageWikiLink Q1077823.
- Q408588 wikiPageWikiLink Q1123260.
- Q408588 wikiPageWikiLink Q116275.
- Q408588 wikiPageWikiLink Q131755.
- Q408588 wikiPageWikiLink Q1429154.
- Q408588 wikiPageWikiLink Q14820686.
- Q408588 wikiPageWikiLink Q14864419.
- Q408588 wikiPageWikiLink Q14865372.
- Q408588 wikiPageWikiLink Q14874257.
- Q408588 wikiPageWikiLink Q14891424.
- Q408588 wikiPageWikiLink Q156959.
- Q408588 wikiPageWikiLink Q18027426.
- Q408588 wikiPageWikiLink Q18027437.
- Q408588 wikiPageWikiLink Q184674.
- Q408588 wikiPageWikiLink Q185935.
- Q408588 wikiPageWikiLink Q186889.
- Q408588 wikiPageWikiLink Q1869874.
- Q408588 wikiPageWikiLink Q188611.
- Q408588 wikiPageWikiLink Q204711.
- Q408588 wikiPageWikiLink Q238509.
- Q408588 wikiPageWikiLink Q238516.
- Q408588 wikiPageWikiLink Q334477.
- Q408588 wikiPageWikiLink Q3563148.
- Q408588 wikiPageWikiLink Q40878.
- Q408588 wikiPageWikiLink Q411457.
- Q408588 wikiPageWikiLink Q416417.
- Q408588 wikiPageWikiLink Q416632.
- Q408588 wikiPageWikiLink Q42844.
- Q408588 wikiPageWikiLink Q4590759.
- Q408588 wikiPageWikiLink Q5133755.
- Q408588 wikiPageWikiLink Q5404839.
- Q408588 wikiPageWikiLink Q616181.
- Q408588 wikiPageWikiLink Q683498.
- Q408588 wikiPageWikiLink Q7071513.
- Q408588 wikiPageWikiLink Q7334142.
- Q408588 wikiPageWikiLink Q7455053.
- Q408588 wikiPageWikiLink Q76560.
- Q408588 wikiPageWikiLink Q769220.
- Q408588 wikiPageWikiLink Q770260.
- Q408588 wikiPageWikiLink Q824292.
- Q408588 wikiPageWikiLink Q8248726.
- Q408588 wikiPageWikiLink Q8297708.
- Q408588 wikiPageWikiLink Q840646.
- Q408588 wikiPageWikiLink Q8546974.
- Q408588 wikiPageWikiLink Q86.
- Q408588 wikiPageWikiLink Q8732563.
- Q408588 wikiPageWikiLink Q8732564.
- Q408588 wikiPageWikiLink Q899107.
- Q408588 wikiPageWikiLink Q916280.
- Q408588 wikiPageWikiLink Q959457.
- Q408588 atcPrefix "N06".
- Q408588 atcSuffix "AX24".
- Q408588 bioavailability "72.0".
- Q408588 casNumber "163521".
- Q408588 chebi "70707".
- Q408588 iupacName "5".
- Q408588 pubchem "6918313".
- Q408588 unii "S239O2OOV3".
- Q408588 type ChemicalSubstance.
- Q408588 type Drug.
- Q408588 type ChemicalObject.
- Q408588 type Thing.
- Q408588 type Q8386.
- Q408588 comment "Vilazodone (United States trade name Viibryd VEYE-brid) is a serotonergic antidepressant developed by Clinical Data for the treatment of major depressive disorder. The chemical compound was originally developed by Merck KGaA (Germany). Vilazodone was approved by the FDA for use in the United States to treat major depressive disorder in 2011.".
- Q408588 label "Vilazodone".
- Q408588 depiction Vilazodone2DACS4.svg.